Skip to main content

Advertisement

Table 3 Values of V5, V20 and mean lung dose (MLD) in total lung and top 20%, 30% and 40% functional lung regions for all the investigated anatomic treatment plans

From: IMRT treatment plans and functional planning with functional lung imaging from 4D-CT for thoracic cancer patients

Patient Anatomic Functional lung region
  Total lung 20% 30% 40%
  V5 (%) V20 (%) MLD (Gy) V5 (%) V20 (%) MLD (Gy) V5 (%) V20 (%) MLD (Gy) V5 (%) V20 (%) MLD (Gy)
1 11.6 7.1 3.8 5.1 2.6 1.6 7.9 4.4 2.6 9.4 5.6 3.2
2 26.74 16.9 9.3 17.9 9.7 5.5 21 11.8 6.7 22.9 13.4 7.6
3 50.6 18.6 11.07 40.6 15.8 9.4 42.6 17 9.9 42.6 17.4 10
4 25.2 17.8 9.4 16.1 10.6 5.8 19.6 13.3 7.2 22.3 15.5 8.3
5 47.3 16.8 10.3 29.2 8.3 6 36.2 12 7.9 40.1 13.9 8.8
6 41.9 16.2 8.6 27 8.5 5.4 33.9 11.9 6.8 38.1 14.2 7.7
AVG ± STD 33.9 ± 15.1 15.6 ± 4.2 8.7 ± 2.6 22.7 ± 12.3 9.3 ± 4.3 5.6 ± 2.5 26.9 ± 12.9 11.7 ± 4.1 6.9 ± 2.4 29.2 ± 13.1 13.3 ± 4.1 7.6 ± 2.3
7 66.4 30.3 16.7 67.4 31.2 17.1 67.1 30 16.8 67.1 30 16.7
8 34.4 18.3 8.7 38.3 21.8 9.9 36.7 20.4 9.3 36.4 20.2 9.3
9 57.7 25.7 13.2 45 19.3 10.2 51.5 23 11.9 55.5 25.1 12.9
10 62.1 27.2 14.4 64.1 26 14.1 62.3 25.3 13.7 61.1 25 13.6
11 46.7 29.5 17.8 31.4 13.3 9.2 37.4 18.5 12.1 40.9 22.1 14
AVG ± STD 53.5 ± 12.9 26.2 ± 4.8 14.2 ± 3.6 49.2 ± 15.9 22.3 ± 6.8 12.1 ± 3.4 51.0 ± 13.9 23.4 ± 4.5 12.7 ± 2.7 52.2 ± 13.1 24.5 ± 3.7 13.2 ± 2.5